BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27765601)

  • 1. Mesenchymal stromal/stem cells in drug therapy: New perspective.
    Sherman LS; Shaker M; Mariotti V; Rameshwar P
    Cytotherapy; 2017 Jan; 19(1):19-27. PubMed ID: 27765601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering mesenchymal stem cells for regenerative medicine and drug delivery.
    Park JS; Suryaprakash S; Lao YH; Leong KW
    Methods; 2015 Aug; 84():3-16. PubMed ID: 25770356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered mesenchymal stromal cells in cancer gene therapy.
    Matuskova M; Durinikova E; Altaner C; Kucerova L
    Bratisl Lek Listy; 2018; 119(4):221-223. PubMed ID: 29663820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult mesenchymal stem cells and their potency in the cell-based therapy.
    Das M; Sundell IB; Koka PS
    J Stem Cells; 2013; 8(1):1-16. PubMed ID: 24459809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mesenchymal stem cells in oncology and regenerative medicine.
    Khan M; Adil SE; Olson AL
    Future Oncol; 2017 Apr; 13(9):821-831. PubMed ID: 27908206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe.
    Kidd S; Spaeth E; Klopp A; Andreeff M; Hall B; Marini FC
    Cytotherapy; 2008; 10(7):657-67. PubMed ID: 18985472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.
    Hall B; Dembinski J; Sasser AK; Studeny M; Andreeff M; Marini F
    Int J Hematol; 2007 Jul; 86(1):8-16. PubMed ID: 17675260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis.
    Kusadasi N; Groeneveld AB
    Shock; 2013 Nov; 40(5):352-7. PubMed ID: 24088992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology for mesenchymal stem cell therapies.
    Corradetti B; Ferrari M
    J Control Release; 2016 Oct; 240():242-250. PubMed ID: 26732556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche.
    Kobolak J; Dinnyes A; Memic A; Khademhosseini A; Mobasheri A
    Methods; 2016 Apr; 99():62-8. PubMed ID: 26384580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing mesenchymal stem cell homing as an anticancer therapy.
    Hagenhoff A; Bruns CJ; Zhao Y; von Lüttichau I; Niess H; Spitzweg C; Nelson PJ
    Expert Opin Biol Ther; 2016 Sep; 16(9):1079-92. PubMed ID: 27270211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Stability of Mesenchymal Stromal Cells for Regenerative Medicine Applications: A Fundamental Biosafety Aspect.
    Neri S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?
    Bernardo ME; Pagliara D; Locatelli F
    Bone Marrow Transplant; 2012 Feb; 47(2):164-71. PubMed ID: 21478914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells in regenerative medicine: Focus on articular cartilage and intervertebral disc regeneration.
    Richardson SM; Kalamegam G; Pushparaj PN; Matta C; Memic A; Khademhosseini A; Mobasheri R; Poletti FL; Hoyland JA; Mobasheri A
    Methods; 2016 Apr; 99():69-80. PubMed ID: 26384579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Host immune and mesenchymal stem cells-based bone regeneration].
    Liu Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Oct; 52(10):620-624. PubMed ID: 29972936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesenchymal stem cells: weapons or dangers for cancer treatment?].
    Lazennec G
    Med Sci (Paris); 2011 Mar; 27(3):285-8. PubMed ID: 21447301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.
    Dothel G; Raschi E; Rimondini R; De Ponti F
    World J Gastroenterol; 2016 Nov; 22(41):9057-9068. PubMed ID: 27895395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
    Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
    Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles.
    Hall B; Andreeff M; Marini F
    Handb Exp Pharmacol; 2007; (180):263-83. PubMed ID: 17554513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.
    Baldari S; Di Rocco G; Piccoli M; Pozzobon M; Muraca M; Toietta G
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28974046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.